Tirzepatide has emerged as a groundbreaking medication for type 2 diabetes, offering promising effects. However, the expense of this innovative drug and its availability have become key topics for patients and healthcare providers. While tirzepatide has been authorized by regulatory agencies, its high-priced nature presents a significant obstacle